Clinical Trial Update: ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) [Phase 2]

View source ↗

Summary

Phase II study evaluating activity of trabectedin in malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED